Page 47 - Read Online

Page 331 Casas-Alba et al. J Transl Genet Genom 2022;6:322-32 https://dx.doi.org/10.20517/jtgg.2022.03

accessed on 9 June 2022].
16. Manickam K, McClain MR, Demmer LA, et al; Exome and genome sequencing for pediatric patients with congenital anomalies or
intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
Genet Med 2021;23:2029-37. DOI PubMed
17. Manning M, Hudgins L; Array-based technology and recommendations for utilization in medical genetics practice for detection of
chromosomal abnormalities.
Genet Med 2010;12:742-5. DOI PubMed
18. Health (Quality). Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health
Technology Assessment. Ont Health Technol Assess Ser 2020;20:1. PubMed
19. Rajagopalan R, Murrell JR, Luo M, Conlin LK. A highly sensitive and specific workflow for detecting rare copy-number variants from
exome sequencing data. Genome Med 2020;12:14. DOI PubMed PMC
20. Srivastava S, Love-Nichols JA, Dies KA, et al; Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-
tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Genet Med 2019;21:2413-21. DOI PubMed
21. Gardner EJ, Prigmore E, Gallone G, et al. Contribution of retrotransposition to developmental disorders. Nat Commun 2019;10:4630.
DOI PubMed PMC
22. Wang Q, Shashikant CS, Jensen M, Altman NS, Girirajan S. Novel metrics to measure coverage in whole exome sequencing datasets
reveal local and global non-uniformity. Sci Rep 2017;7:885. DOI PubMed PMC
23. Mantere T, Kersten S, Hoischen A. Long-read sequencing emerging in medical genetics. Front Genet 2019;10:426. DOI PubMed
PMC
24. Bamshad MJ, Nickerson DA, Chong JX. Mendelian gene discovery: fast and furious with no end in sight. Am J Hum Genet
2019;105:448-55. DOI PubMed PMC
25. Wenger AM, Guturu H, Bernstein JA, Bejerano G. Systematic reanalysis of clinical exome data yields additional diagnoses:
implications for providers. Genet Med 2017;19:209-14. DOI PubMed
26. Gardner EJ, Sifrim A, Lindsay SJ, et al. Detecting cryptic clinically relevant structural variation in exome-sequencing data increases
diagnostic yield for developmental disorders. Am J Hum Genet 2021;108:2186-94. DOI PubMed PMC
27. Basel-Salmon L, Orenstein N, Markus-Bustani K, et al. Improved diagnostics by exome sequencing following raw data reevaluation
by clinical geneticists involved in the medical care of the individuals tested. Genet Med 2019;21:1443-51. DOI PubMed
28. Salinas V, Martínez N, Maturo JP, et al. Clinical next generation sequencing in developmental and epileptic encephalopathies:
Diagnostic relevance of data re-analysis and variants re-interpretation. Eur J Med Genet 2021;64:104363. DOI PubMed
29. Bullich G, Matalonga L, Pujadas M, et al; Systematic collaborative reanalysis of genomic data improves diagnostic yield in neurologic
rare diseases.
J Mol Diagn 2022;24:529-42. DOI PubMed
30. McNulty SN, Evenson MJ, Corliss MM, et al. Diagnostic utility of next-generation sequencing for disorders of somatic mosaicism: a
five-year cumulative cohort. Am J Hum Genet 2019;105:734-46. DOI PubMed PMC
31. Krawczynska N, Wierzba J, Wasag B. Genetic mosaicism in a group of patients with cornelia de lange syndrome. Front Pediatr
2019;7:203. DOI PubMed PMC
32. Jamuar SS, Lam AT, Kircher M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014;371:733-43. DOI
PubMed PMC
33. Stutterd CA, Brock S, Stouffs K, et al. Genetic heterogeneity of polymicrogyria: study of 123 patients using deep sequencing. Brain
Commun 2021;3:fcaa221. DOI PubMed PMC
34. Bi W, Borgan C, Pursley AN, et al. Comparison of chromosome analysis and chromosomal microarray analysis: what is the value of
chromosome analysis in today’s genomic array era? Genet Med 2013;15:450-7. DOI PubMed
35. Astbury C, Christ LA, Aughton DJ, et al. Detection of deletions in de novo "balanced" chromosome rearrangements: further evidence
for their role in phenotypic abnormalities. Genet Med 2004;6:81-9. DOI PubMed
36. Aref-Eshghi E, Schenkel LC, Lin H, et al. Clinical validation of a genome-wide DNA methylation assay for molecular diagnosis of
imprinting disorders. J Mol Diagn 2017;19:848-56. DOI PubMed
37. Aref-Eshghi E, Bend EG, Colaiacovo S, et al. Diagnostic utility of genome-wide DNA methylation testing in genetically unsolved
individuals with suspected hereditary conditions. Am J Hum Genet 2019;104:685-700. DOI PubMed PMC
38. Sadikovic B, Levy MA, Kerkhof J, et al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of
Mendelian disorders. Genet Med 2021;23:1065-74. DOI PubMed
39. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria
syndrome. Nature 2003;423:293-8. DOI PubMed
40. Luo HM, Zhang Y, Wang XQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med
2013;369:1981-90. DOI PubMed
41. Cummings BB, Marshall JL, Tukiainen T, et al; Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.
Sci Transl Med 2017;9:eaal5209. DOI PubMed
42. Kremer LS, Bader DM, Mertes C, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun 2017;8:15824.
DOI PubMed PMC